CBD Life Sciences Inc. (OTCMKTS:CBDL) Short Interest Down 65.6% in April

CBD Life Sciences Inc. (OTCMKTS:CBDLGet Rating) saw a significant decline in short interest during the month of April. As of April 30th, there was short interest totalling 169,300 shares, a decline of 65.6% from the April 15th total of 492,500 shares. Based on an average trading volume of 91,163,800 shares, the days-to-cover ratio is currently 0.0 days.

CBD Life Sciences stock traded down $0.00 during trading on Thursday, reaching $0.00. The stock had a trading volume of 28,747,028 shares, compared to its average volume of 83,192,695. CBD Life Sciences has a 52-week low of $0.00 and a 52-week high of $0.00.

CBD Life Sciences Company Profile (Get Rating)

CBD Life Sciences Inc engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a line of pet products. The company is based in Scottsdale, Arizona.

See Also

Receive News & Ratings for CBD Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CBD Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.